You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 27, 2026

Drugs Containing Excipient (Inactive Ingredient) PROPYLENE GLYCOL


✉ Email this page to a colleague

« Back to Dashboard


Branded drugs containing PROPYLENE GLYCOL excipient, and estimated key patent expiration / generic entry dates

Generic drugs containing PROPYLENE GLYCOL excipient

Market Dynamics and Financial Trajectory for Propylene Glycol

Last updated: February 20, 2026

What is the Current Market Size and Growth Rate?

The global propylene glycol (PG) market was valued at approximately USD 2.9 billion in 2022. It is projected to grow at a compound annual growth rate (CAGR) of 5.2% from 2023 through 2030, reaching an estimated USD 4.3 billion by 2030 (Grand View Research, 2023).

Key Market Drivers

  • Expanding pharmaceutical applications, including oral, injectable, and topical drugs.
  • Rising demand in cosmetics, personal care, and food industries due to PG’s moisturizing and preservative properties.
  • Increasing adoption in industrial applications, such as antifreeze and hydraulic fluids.

Market Segments

Segment Share (2022) Growth Outlook Key Applications
Pharmaceutical 35% Growing with new formulations and delivery systems Oral solutions, injectables, topical creams
Food & Beverages 25% Steady growth driven by preservative use Food additives, flavor carriers
Personal Care 20% Rapid growth driven by skincare and cosmetics Moisturizers, anti-aging products
Industrial 20% Moderate growth, driven by automotive and chemical industries Antifreeze, lubricants

Regional Market Analysis

Region Market Share (2022) CAGR (2023-2030) Notable Trends
Asia-Pacific 45% 6.0% Dominates due to manufacturing hubs in China, India; expanding pharmaceutical industry
North America 22% 4.5% Growth driven by cosmetics and pharmaceuticals
Europe 20% 4.2% Focus on sustainable production and regulatory compliance
Rest of World 13% 4.7% Growing industrial applications

Regulatory and Supply Chain Factors

  • Approval by agencies such as the US Food and Drug Administration (FDA) and European Medicines Agency (EMA) facilitates pharmaceutical use.
  • Major producers include Dow Chemical and LyondellBasell, commanding roughly 60% of global supply.
  • Supply chain disruptions, such as raw material shortages or logistics delays, impact pricing and availability.

Financial Trajectory and Market Competition

Company Market Share (Approximate) Financial Overview Strategic Moves
Dow Chemical 30% Revenue: USD 55 billion (2022); PG sales part of chemicals division Investment in capacity expansion; sustainability initiatives
LyondellBasell 15% Revenue: USD 50 billion (2022); PG segment growth focus Capacity expansion; R&D in bio-based PG
BASF 10% Revenue: USD 89 billion (2022); diversified excipients portfolio Partnership with biotech firms; sustainable product development
Other regional and specialty companies 45% Varying revenues and capacities Focus on niche markets and bio-based PG production

Pricing Trends

  • Price fluctuation correlates with crude oil prices, as propylene is derived from propane.
  • From 2019 to 2022, prices ranged between USD 1.20 and USD 1.50 per kg.
  • Recent escalation to USD 1.70 per kg in 2023 signifies supply constraints and raw material cost increases.

Strategic Factors Impacting Future Growth

  • Increasing shift toward bio-based PG to meet sustainability standards.
  • Regulatory hurdles delaying new approvals for certain pharmaceutical and food applications.
  • R&D investments targeting higher purity grades and specialty formulations.
  • Expansion in emerging markets driven by infrastructure development and healthcare investments.

Key Takeaways

  • The propylene glycol market exhibits steady growth, fueled by pharmaceutical, food, personal care, and industrial applications.
  • Asia-Pacific dominates the market, with a 45% share in 2022, and maintains the highest CAGR.
  • Major companies lead with substantial market shares, investing heavily in capacity expansion and sustainability.
  • Price sensitivity to crude oil prices remains a critical factor influencing profitability and supply stability.
  • Regulatory dynamics and sustainability trends significantly influence R&D and production strategies.

FAQs

  1. What are the main pharmaceutical uses of propylene glycol? They include solvent carrier in oral and injectable medications, and excipients in topical formulations.
  2. How does bio-based PG affect the market? It meets rising sustainability standards, appeals to environmentally conscious sectors, but faces higher production costs.
  3. What regions are expected to see the fastest growth? Asia-Pacific and Latin America due to expanding manufacturing and healthcare industries.
  4. Are market prices for propylene glycol volatile? Yes, prices fluctuate with crude oil prices and raw material availability.
  5. What regulatory challenges exist for PG producers? Approval procedures for pharmaceutical and food-grade PG can be lengthy, especially for bio-based variants.

References

  1. Grand View Research. (2023). Propylene glycol market size, share & trends analysis report.
  2. LyondellBasell. (2022). Annual report.
  3. Dow Chemical. (2022). Financial statements.
  4. BASF. (2022). Sustainability report.
  5. MarketsandMarkets. (2023). Food & beverage excipients market report.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.